Concepedia

Author

Thomas Sears

University of California, DavisORCID

Also Known As

Thomas K Sears, Thomas K. Sears, Thomas Sears

32

Publications

218

Citations

7

H-Index

7

Concepts

All Affiliations

University of California, DavisNeurological SurgeryNorthwestern University
TS

About

Thomas Sears is an author at University of California, Davis specializing in medicine, pharmacology, and molecular pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

11

2

Cell Biology

1

1

11

3

Pharmacology

1

1

11

4

Molecular Pharmacology

1

1

11

5

Cancer Biology

1

1

11

Thomas Sears

×

5

Publications

121

Citations

5

H-Index

YearCitations

Postoperative risk of IDH mutant glioma–associated seizures and their potential management with IDH mutant inhibitors

Michael Drumm, Wenxia Wang, Thomas Sears,

Journal of Clinical Investigation

2023

45

Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells

Sandipan Datta, Thomas Sears, Gino Cortopassi,

Biomedicine & Pharmacotherapy

2020

33

IDH1 mutant glioma is preferentially sensitive to the HDAC inhibitor panobinostat

Thomas Sears, Craig Horbinski, Kevin Woolard

Journal of Neuro-Oncology

2021

17

Modeling Therapy-Driven Evolution of Glioblastoma with Patient-Derived Xenografts

Matthew McCord, Elizabeth T. Bartom, Kirsten B. Burdett,

Cancers

2022

15

Cetylpyridinium chloride is a potent AMP-activated kinase (AMPK) inducer and has therapeutic potential in cancer

Sonia Allen, Sandipan Datta, José Armando Pancorbo Sandoval,

Mitochondrion

2019

11

Page 1